Niveau de preuve du suivi therapeutique pharmacologique de la névirapine-Reference-Cited by-同舟云学术

Niveau de preuve du suivi therapeutique pharmacologique de la névirapine

Published:2011-05 Issue:3 Volume:66 Page:187-195
ISSN:0040-5957
Container-title:Therapies
language:fr
Short-container-title:Therapies

Author:

Muret Patrice,Piedoux Sarah,Solas Caroline,Quaranta Sylvie

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference36 articles.

1. Clinical pharmacokinetics of nonnucleoside reverse transcriptase inhibitors;Smith;Clin Pharmacokinet,2001

2. Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice;Molto;Br J Clin Pharmacol,2007

3. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption;Darwich;Antivir Ther,2008

4. Méthodologie pour l’évaluation du niveau de preuve du suivi thérapeutique pharmacologique;Le Guellec;La lettre du Pharmacologue,2009

5. Prise en charge médicale des personnes infectées par le VIH;Yeni,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice;Current HIV Research;2019-10-23

2. Nevirapine Concentrations in Saliva Measured by Thin Layer Chromatography and Self-Reported Adherence in Patients on Antiretroviral Therapy at Kilimanjaro Christian Medical Centre, Tanzania;Therapeutic Drug Monitoring;2014-06

3. Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique;Therapies;2014-05